Trials / Recruiting
RecruitingNCT06902285
Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty
Use of Magnesium-L-Threonate to Improve Subjective Sleep Quality After Total Joint Arthroplasties: Randomized Controlled Clinical Trial
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study team is conducting a study to see if Magnesium-L-Threonate (MgT) can help improve how well participants sleep and reduce pain after total joint replacement surgery
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium Threonate | Participants will receive a daily 145 mg pill by mouth 30 minutes before going to sleep |
| OTHER | Control | Participants will receive two sugar pills daily by mouth 30 minutes before going to sleep |
Timeline
- Start date
- 2025-04-21
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2025-03-30
- Last updated
- 2025-04-24
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06902285. Inclusion in this directory is not an endorsement.